- EnteroMedics Inc ETRM climbed 93.3 percent to $4.04 after surging 11.17 percent on Wednesday. EnteroMedics disclosed that its vBloc® Neurometabolic Therapy is now available at MedStar Health in Maryland and Roper St. Francis in South Carolina.
- Prana Biotechnology Limited (ADR) PRAN shares jumped 32.1 percent to $2.55. Prana Biotechnology shares have dropped 54.05 percent over the past 52 weeks, while the S&P 500 index has increased 12.60 percent in the same period.
- Pieris Pharmaceuticals Inc PIRS shares climbed 28.8 percent to $1.88. Pieris Pharmaceuticals and Servier reported a broad collaboration in immuno-oncology.
- CEB Inc. CEB shares surged 21.8 percent to $75.30 after Gartner Inc IT announced plans to acquire the company for $2.6 billion in cash and stock.
- CTI BioPharma Corp CTIC shares jumped 21.2 percent to $4.81 after the company reported the removal of full clinical hold on pacritinib.
- Microbot Medical Inc MBOT gained 16.8 percent to $8.89 after the company reported a 700,000 share direct offering for $3.5 million.
- Bonanza Creek Energy Inc BCEI surged 16.7 percent to $1.61. On Wednesday, Bonanza Creek Energy announced that it has filed voluntary petitions under Chapter 11 of the United States Bankruptcy Code in the Bankruptcy Court for the District of Delaware to pursue a prepackaged plan of reorganization.
- Alexco Resource Corp. (USA) AXU shares rose 14 percent to $1.71. Alexco Resource shares have jumped 328.57 percent over the past 52 weeks, while the S&P 500 index has gained 12.60 percent in the same period.
- Halozyme Therapeutics, Inc. HALO shares climbed 12.8 percent to $12.06 after the company disclosed that its Phase 2 study in advanced pancreas cancer achieved key endpoints.
- First Majestic Silver Corp AG rose 12.5 percent to $9.42. Silver futures gained 1.17 percent to trade at $16.75 an ounce.
- Otonomy Inc OTIC gained 11.4 percent to $18.05 after the company reported positive top-line results from its Phase 3 clinical trial of OTIPRIO.
- Genocea Biosciences Inc GNCA shares rose 8.2 percent to $4.91 after announcing positive 6-month results from GEN-003 Phase 2b clinical trial.
- Alexion Pharmaceuticals, Inc. ALXN shares surged 8.2 percent to $137.52. Alexion filed its delayed report for the third quarter and affirmed its FY16 guidance. The Audit and Finance Committee concluded there is no need to restate financials based on the investigation.
- Evoke Pharma Inc EVOK shares gained 7.4 percent to $2.89 after climbing 29.95 percent on Wednesday. Rodman & Renshaw upgraded Evoke Pharma from Neutral to Buy.
- Sears Holdings Corp SHLD shares rose 5 percent to $10.87. Stanley Black & Decker SWK agreed to buy the Craftsman brand from Sears for around $900 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
